Principles of infection management in community-based burns care

Size: px
Start display at page:

Download "Principles of infection management in community-based burns care"

Transcription

1 Principles of infection management in community-based burns care White R et al (2012) Principles of infection management in community-based burns care. Nursing Standard. 27, 2, Date of acceptance: August Abstract The development of infection in a burn can lead to poor healing outcomes and possibly sepsis. Although most patients with burns treated in the primary care setting are unlikely to develop life-threatening infections, clinicians would still benefit from an understanding of the factors that may increase the risk of infection, signs and symptoms of infection, and when to seek specialist advice. Authors Richard White Professor of tissue viability, University of Worcester. Beverley Swales Burns educator in Yorkshire and Humber. Martyn Butcher Independent tissue viability and wound care consultant, Devon. Correspondence to: m.butcher_woundcare@hotmail.com Keywords Burns, dressings, infection, primary care, sepsis, wound care Review All articles are subject to external double-blind peer review and checked for plagiarism using automated software. Online Guidelines on writing for publication are available at For related articles visit the archive and search using the keywords above. The skin ACTS AS a barrier to the external environment, protecting the delicate structures of the body from trauma, desiccation and infection. When this barrier is breached, for example as a result of a burn, this protection is lost, exposing tissues to the environment and potentially enabling pathogenic organisms to multiply and cause infection. Infection is considered one of the primary complications of a burn (Norman 2003). There is a vast spectrum of burns that may be seen in clinical practice, ranging from those that are superficial to those that are severe, extensive and life-threatening, necessitating surgical reconstruction. Therefore, the potential for severe sepsis the destruction of tissues by pathogenic bacteria or their toxins differs depending on the type of burn. Risk of infection All burns have the potential to become infected. At the time of injury, the burn wound is practically sterile, but it rapidly acquires bacterial flora (bioburden) (Zellner and Bugyi 1985). Whether this bioburden progresses into infection depends on many factors. Burns factors Factors relating to the burn itself that may increase the risk of infection include: Size of the burn the greater the area of the body affected, the greater the demands placed on the body s immune system (Rawlins 2011). In addition, there is increased opportunity for bacterial contamination (Santaniello et al 2004). Depth of the burn deep dermal and full-thickness burns result in significant tissue necrosis, providing a source of denatured protein and encouraging bacterial proliferation (Williams 2002). Cause of the burn burn aetiology is a determinant of burn depth (Rawlins 2011). Exposure to high temperature is more likely to result in full-thickness damage (Zadeh et al 2008). Similarly, electrical burns may result in tissue damage and necrosis some distance away from the visible entry and exit point wounds (Hermans 2005). Location of the burn some areas of the body, such as the perineum, have a naturally high skin flora. These areas form a bacterial reservoir able to colonise the burn (Cooper 2003). In addition, some areas have reduced skin thickness, such as the dorsum of the hands and feet, potentially increasing the depth of damage (Hermans 2005). Patient factors Patient factors that may increase the risk of infection include: 64 september 12 :: vol 27 no 2 :: 2012 NURSING STANDARD / RCN PUBLISHING

2 Age of the person younger and older patients have thinner skin, increasing the risk of full-thickness burns (Dowsett 2002). In addition, these individuals may have reduced immune status, which affects the body s ability to control bioburden (Castle 2000, Holt and Jones 2000). Pre-existing co-morbidities the presence of systemic disease, for example circulatory and respiratory disease, may affect the patient s ability to maintain adequate tissue oxygenation or the body s immune response (Parker 2002). Management factors Management factors that may increase the risk of infection include: First aid failure to provide adequate cooling of the burn immediately after injury can result in progression of tissue damage through heat transference to deeper tissues (Yuan et al 2007). Cooling the burn with a contaminated water supply may increase the number of pathogens present in the wound (Williams 2009). Age of the burn at presentation exposure of the burn to environmental contamination, which tends to occur when the individual presents late to the healthcare setting, can lead to high levels of bioburden. Fluid resuscitation inadequate fluid resuscitation leads to peripheral shutdown and can result in increasing burn depth and full-thickness skin loss (Benson et al 2006). Topical treatments inappropriate dressing selection can result in burn desiccation, increasing burn depth; insufficient burn coverage, enabling bacterial contamination; and dressing adherence, causing trauma to the burn and surrounding tissues, and pain (Hermans 2005). The presence of infection in a burn may increase the depth of tissue damage, complicate recovery and delay healing (Butcher 2011). Robson (1979) identified infection as a particular concern in large deep dermal and full-thickness burns as a result of impaired local and systemic immunity and the presence of devitalised tissue. Hudspith and Rayatt (2004) stated that in non-complex burns, the risk and prevalence of infection are low. This reduced risk is attributed to the scale of the insult to skin barrier function, the expected length of time needed to re-establish skin integrity through healing and the amount of debris or necrotic burden in the wound. However, the term non-complex burn can be difficult to interpret. Complexity is a relative term that relates to the depth and extent of a burn, but also includes factors such as the location of the wound, ability of the patient to self-care, need for surgical reconstruction and risk of infection. The National Network for Burn Care (NNBC) (2012) guidelines provide information about when specialist burns care advice should be sought and when patients should be referred for expert assessment and treatment. Reducing the risk of infection There are several areas where the risk of infection in a burn can be reduced. Patients presenting with a burn require up-to-date tetanus prophylaxis (Rawlins 2011). Debris in the wound provides an ideal environment for bacterial proliferation and the clinician should remove as much debris as possible (Alsbjörn et al 2007). Cleansing should be gently carried out with a warm soap and water or sodium chloride solution (Alsbjörn et al 2007). It is considered acceptable to leave burn blisters less than 1cm in diameter intact (Hudspith and Rayatt 2004). Larger blisters should be aspirated and aseptically removed using scissors (Dowsett 2002), therefore reducing the risk of necrotic tissue forming a site for the development of infection (Senarath-Yapa and Enoch 2009). However, the burn area and all blisters should be covered with an appropriate sterile wound dressing (Hermans 2005). The majority of burns managed in the primary care setting will be epidermal and/or superficial partial-thickness wounds (NNBC 2012). These burns affect only the outermost areas of the skin and are likely to heal within two weeks, provided that a moist wound environment is maintained and infection is prevented (Papini 2004). Some localised deeper burns may be managed in the community following discussion with a specialist burns consultant and where surgical reconstruction is contraindicated as a result of existing co-morbidities (NNBC 2012). Butcher (2011) identified that dressings used to treat burns should be able to maintain a moist wound environment, and manage exudate, bioburden and pain. The beneficial role of dressings capable of maintaining a moist wound environment in superficial burns management is recognised (Lloyd et al 2012). Extensive research and clinical experience has established that moist wound healing is safe and effective (Alsbjörn et al 2007). Desiccation of the wound bed impedes delivery of nutrients and immune defences to the wound surface, as well as the capability of cells to migrate across the wound surface. In superficial burn healing, this epidermal migration results in wound repair (Papini 2004). Re-epithelialisation on a dry surface may be slow as the cells must advance beneath the scab or eschar. Semi-occlusive dressings such as semi-permeable film dressings and hydrocolloid dressings act as an artificial epidermis, providing a barrier to reduce fluid loss, NURSING STANDARD / RCN PUBLISHING september 12 :: vol 27 no 2 ::

3 maintaining a moist environment and excluding environmental contaminants and bacteria (Dowsett 2002). The burn affects the microcirculation, leading to increased capillary permeability. This results in oedema and high exudate levels in the immediate post-injury period (24-72 hours) (Rawlins 2011). Dressings need to be able to absorb exudate without saturation. If saturation occurs, exudate can leak through the outer layers of the dressing (strike-through) and provides a route for bacterial ingress. Alginate and hydrofibre dressings have been used successfully to manage burn exudate (Dowsett 2002, Green 2011). However, these dressings require secondary wound care products to maintain a moist environment and enable dressing retention (Alsbjörn et al 2007). Foam dressings, particularly when combined with an atraumatic wound interface material, can control wound exudate, prevent bacterial contamination and protect delicate tissues from desiccation and trauma during dressing changes (Butcher 2011, Green 2011). Conservative management of localised, full-thickness burns requires a moist wound environment where autolysis (natural sloughing) of the devitalised tissue can take place to reduce necrotic and bacterial burden (Young 2011). These burns may also benefit from the use of hydrocolloid or film dressings (Stephen-Haynes and Thompson 2007). However, it may be necessary to increase moisture levels to encourage autolysis. This type of full-thickness burn may benefit from the use of hydrogel dressings (Edwards 2010). Where burns are contaminated or there is an increased risk of bacterial colonisation and infection, dressings with antimicrobial properties are indicated (Wounds UK 2011, Wounds International 2012). The frequency of dressing change is also an important factor. The burn requires regular inspection until the full extent of burn depth is realised. However, once burn depth is accurately estimated, reduced frequency of dressing change is indicated to minimise the risk of bacterial contamination and trauma to the wound (Senarath-Yapa and Enoch 2009). Recognising infection It is important that the clinician remains vigilant to the signs and symptoms of infection. Although severe sepsis in burns managed in the community setting is rare (Hudspith and Rayatt 2004), the clinician should seek advice from a specialist burns consultant if infection is suspected (NNBC 2012). Identifying infection in burns can be difficult. Many of the cardinal signs of infection, such as erythema, high levels of exudate and pain (Cutting and Harding 1994) may be present in the non-infected burn as part of the normal response to burns trauma. Additional signs of infection may include increasing wound exudate or opaque exudate, development of discolouration in the burn or surrounding skin, malodour, increasing burn depth or spreading skin loss, or fragility of the wound bed with bleeding (European Wound Management Association (EWMA) 2005). Swabs should be taken to refine treatment interventions by identifying causative organisms and specific antibiotic sensitivities, however these will take time to process. The diagnosis of infection should not be delayed and will be based on clinical presentation. It is also important to be aware of the risk of toxic shock syndrome (TSS). This life-threatening complication can arise in the burn if infection with specific strains of Staphylococcus aureus occurs. Although uncommon, TSS typically affects young children with a burn of less than 10% of the total body surface area, which might otherwise be expected to heal uneventfully (White et al 2005). The nnbc (2012) guidelines state that if there are any suspicions that the patient with a burn injury has TSS, he or she should be referred to a specialist burns unit immediately. Managing infection If infection occurs, it may be necessary to hospitalise the patient. However, localised infection may be managed in the primary care setting (NNBC 2012). Appropriate antibiotics should be commenced and antimicrobial dressings should be used to reduce bioburden (EWMA 2006). The burn may become infected with a variety of organisms, including S. aureus, Streptococcus spp., Pseudomonas aeruginosa and other microorganisms such as Acinetobacter baumannii, S. epidermidis, Aeromonas hydrophila and anaerobic bacteria (Thomas et al 2005). Historically, the focus of treatment of infection in burns has been on large and severe burns and on the use of parenteral antibiotics. However, antibiotics should be reserved for the management of confirmed sepsis (Mertens et al 1997, Fowler 2006). Topical treatments such as the use of dressings containing antimicrobial properties can be used to control bioburden (EWMA 2005). This may be appropriate for individuals at particular risk of infection or where significant contamination of the burn has occurred (Wounds UK 2011). Management of this nature is safe and inexpensive and ensures only bacteria within the burn are targeted, therefore eliminating the 66 september 12 :: vol 27 no 2 :: 2012 NURSING STANDARD / RCN PUBLISHING

4 potential side effects of antibiotic use and reducing the development of resistant bacterial strains (Wounds UK 2011). Wounds UK (2011) suggests that the ideal wound antiseptic should be: Effective against likely pathogens. Fast acting, with prolonged residual activity after a single dose. Inexpensive. Incapable of selecting for bacterial resistance. Unlikely to be absorbed systemically. Non-carcinogenic and non-teratogenic to host cells. Non-toxic. Widely available. It should be noted that concern has arisen over the cost, effectiveness and safety of long-term antimicrobial use (Denyer 2009, Michaels et al 2009). However, reviews have found antimicrobials to be safe and effective if used correctly (White et al 2006, Lipsky and Hoey 2009). Guidance on the use of antimicrobials includes product selection, criteria for judging effectiveness and recommendations for duration of use (Wounds UK 2011). Antimicrobial activity has been recognised as an essential component of the ideal burn dressing (Selig et al 2012). Povidone iodine (Norman 2003), honey (Wijesinghe et al 2009, Malik et al 2010) and polihexanide (Daeschlein et al 2007, Dissemond et al 2011) have been used successfully in the treatment of burns. The most common agent used in burns management is silver, for example silver sulfadiazine 1% cream (Hermans 2007). However, this cream is relatively short acting, requires at least daily re-application, and is time consuming and messy to apply and remove. It can also lead to build up of discoloured slurry on the wound making assessment difficult (Silverstein et al 2011). The use of silver sulfadiazine 1% cream for minor burns is not recommended (Chung and Herbert 2001). Indeed, detailed analysis of evidence has found that silver sulfadiazine References Alsbjörn B, Gilbert P, Hartmann B et al (2007) Guidelines for the management of partial-thickness burns in a general hospital or community setting recommendations of a European working party. Burns. 33, 2, Benson A, Dickson WA, Boyce DE (2006) ABC of wound healing: burns. British Medical Journal. 332, 7542, Butcher M (2011) Meeting the clinical challenges of burns management: a review. British Journal of Nursing. 20, 15, S44-S51. Castle SC (2000) Clinical relevance of age-related immune dysfunction. Clinical Infectious Diseases. 31, 2, Chung JY, Herbert ME (2001) Myth: silver sulfadiazine is the best treatment for minor burns. Western Journal of Medicine. 175, 3, Cooper R (2003) The contribution of microbial virulence to wound infection. In White RJ (Ed) The Silver Book. Quay Books, Bath, Cutting KF, Harding KG (1994) Criteria for identifying wound infection. Journal of Wound Care. 3, 4, Daeschlein G, Assadian O, Bruck JC, Meinl C, Kramer A, Koch S (2007) Feasibility and clinical applicability of polihexanide for treatment of second-degree burn wounds. Skin Pharmacology and Physiology. 20, 6, Denyer J (2009) Epidermal bullosa and silver absorption in paediatrics. Conference presentation. Wounds UK Conference, November 11, Harrogate, UK. Dissemond J, Assadian O, Gerber V et al (2011) Classification of wounds at risk and their antimicrobial treatment with polihexanide: a practice-oriented expert recommendation. Skin Pharmacology and Physiology. 24, 5, Dowsett C (2002) The assessment and management of burns. British Journal of Community Nursing. 7, 5, Edwards J (2010) Hydrogels and their potential uses in burn wound management. British Journal of Nursing. 19, 11, S12-S16. European Wound Management Association (2005) Position Document: Identifying Criteria for Wound Infection. Medical Education Partnership, London. European Wound Management Association (2006) Position Document: Management of Wound Infection. Medical Education Partnership, London. Fowler A (2006) Atraumatic dressings for non-complex burns. Practice Nursing. 17, 4, Green B (2011) A basic introduction to minor burns. Professional Nursing Today. 15, 4, Hermans MH (2005) A general overview of burn care. International Wound Journal. 2, 3, Hermans MH (2007) Results of an internet survey on the treatment of partial thickness burns, full thickness burns and donor sites. Journal of Burn Care and Research. 28, 6, Holt PG, Jones CA (2000) The development of the immune system during pregnancy and early life. Allergy. 55, 8, Hudspith J, Rayatt S (2004) First aid and treatment of minor burns. British Medical Journal. 328, 7454, Lipsky BA, Hoey C (2009) Topical antimicrobial therapy for treating chronic wounds. Clinical Infectious Diseases. 49, 10, Lloyd EC, Rodgers BC, Michener M, Williams MS (2012) Outpatient burns: prevention and care. American Family Physician. 85, 1, Malik KI, Malik MA, Aslam A (2010) Honey compared with silver sulphadiazine in the treatment of superficial partial-thickness burns. International Wound Journal. 7, 5, Mertens DM, Jenkins ME, Warden GD (1997) Outpatient burn management. Nursing Clinics of North America. 32, 2, Michaels JA, Campbell B, King B, Palfreyman SJ, Shackley P, Stevenson M (2009) Randomized controlled trial and cost-effectiveness analysis of silver-donating antimicrobial dressings for venous leg ulcers (VULCAN trial). British Journal of Surgery. 96, 10, National Network for Burn Care (2012) National Burn Care Referral Guidance. tiny.cc/burn_care_ guidance (Last accessed: August ) Norman D (2003) The use of povidone-iodine in superficial partial-thickness burns. British NURSING STANDARD / RCN PUBLISHING september 12 :: vol 27 no 2 ::

5 1% cream may prolong healing times and increase pain (Wasiak et al 2008). The development of dressings that combine elemental silver or silver-releasing compounds has provided additional antimicrobial options. The core dressing functions, for example non-adherence to the wound bed, absorption of exudate and/or atraumatic removal, are retained with the benefits of antimicrobial activity. Specific guidelines on the use of silverbased antimicrobial products are available (Wounds International 2012). These dressings should only be used if clinically indicated to manage bioburden and they should be discontinued when no longer required. Treatment should be limited to two weeks initially (Wounds UK 2011, Wounds International 2012). Continuation after this point should be subject to regular reassessment. However, the nnbc (2012) guidelines state that if burns managed in the community have not healed after two weeks then further discussion or referral to a specialist burns unit is indicated. Conclusion Because of the compromised integrity of the skin caused by a burn, infection may have serious consequences if not managed correctly. However, it is important to recognise that severe sepsis is rare in patients whose burns are suitable for management in the community setting. Clinicians need to reduce the risk of infection developing in the burn by reducing potential contamination and bioburden. It is vital that clinicians are aware of the signs and symptoms of infection so that the patient can be referred to a specialist burns unit if necessary NS Conflict of interest This article was supported by Mölnlycke Health Care Journal of Nursing. 12, Suppl 6, S30-S36.Papini R (2004) ABC of burns: management of burn injuries of various depth. British Medical Journal. 329, 7458, Parker L (2002) Applying the principles of infection control to wound care. In: White R, Harding K (Eds) Trends in Wound Care. Quay Books, Bath, Rawlins JM (2011) Management of burns. Surgery. 9, 10, Robson MC (1979) Bacterial control in the burn wound. Clinics in Plastic Surgery. 6, 4, Santaniello JM, Luchette FA, Esposito TJ et al (2004) Ten year experience of burn, trauma, and combined burn/trauma injuries comparing outcomes. Journal of Trauma. 57, 4, Selig HF, Lumenta DB, Giretzlehner M, Jeschke MG, Upton D, Kamolz LP (2012) The properties of an ideal burn wound dressing what do we need in daily clinical practice? Results of a worldwide online survey among burn care specialists. Burns. 38, 3, Senarath-Yapa K, Enoch S (2009) Management of burns in the community. Wounds UK. 5, 2, Silverstein P, Heimbach D, Meites H et al (2011) An open, parallel, randomized, comparative, multicentre study to evaluate the cost-effectiveness, performance, tolerance, and safety of a silver-containing soft silicone foam dressing (intervention) vs silver sulfadiazine cream. Journal of Burn Care and Research. 32, 6, Stephen-Haynes J, Thompson G (2007) The different methods of wound debridement. British Journal of Community Nursing. 12, 6, S6-S16. Thomas JG, Slone W, Linton S, Okel T, Corum L, Percival SL (2005) In vitro antimicrobial efficacy of a silver alginate dressing on burn wound isolates. Journal of Wound Care. 20, 3, Wasiak J, Cleland H, Campbell F (2008) Dressings for superficial and partial thickness burns. Cochrane Database of Systematic Reviews. Issue 4, CD White MC, Thornton K, Young AE (2005) Early diagnosis and treatment of toxic shock syndrome in paediatric burns. Burns. 31, 2, White RJ, Cutting K, Kingsley A (2006) Topical antimicrobials in the control of wound bioburden. Ostomy/Wound Management. 52, 8, Wijesinghe M, Weatherall M, Perrin K, Beasley R (2009) Honey in the treatment of burns: a systematic review and meta-analysis of its efficacy. New Zealand Medical Journal. 122, 1295, Williams C (2009) Successful assessment and management of burn injuries. Nursing Standard. 23, 32, Williams WG (2002) Pathophysiology of burn wounds. In Herndon DN (Ed) Total Burn Care. Second edition. Saunders, London, Wounds International (2012) International Consensus: Appropriate Use of Silver Dressings in Wounds. tiny.cc/silver_dressings (Last accessed: August ) Wounds UK (2011) Best Practice Statement: The Use of Topical Antiseptic/Antimicrobial Agents in Wound Management. Second edition. pdf/content_9969.pdf (Last accessed: August ) Young T (2011) Wound debridement in the community setting. British Journal of Community Nursing. 16, 6, Yuan J Wu C, Holland AJ et al (2007) Assessment of cooling on an acute scald burn injury in a porcine model. Journal of Burn Care and Research. 28, 3, Zadeh BS, Moghimi H, Santos P, Hadgraft J, Lane ME (2008) A comparative study of the in vitro permeation characteristic of sulphadiazine across synthetic membranes and eschar tissue. International Wound Journal. 5, 5, Zellner PR, Bugyi S (1985) Povidone-iodine in the treatment of burn patients. Journal of Hospital Infection. 6, Suppl A, september 12 :: vol 27 no 2 :: 2012 NURSING STANDARD / RCN PUBLISHING

COALINGA STATE HOSPITAL. NURSING POLICY AND PROCEDURE MANUAL SECTION Emergency Procedures POLICY NUMBER: 705. Effective Date: August 31, 2006

COALINGA STATE HOSPITAL. NURSING POLICY AND PROCEDURE MANUAL SECTION Emergency Procedures POLICY NUMBER: 705. Effective Date: August 31, 2006 COALINGA STATE HOSPITAL NURSING POLICY AND PROCEDURE MANUAL SECTION Emergency Procedures POLICY NUMBER: 705 Effective Date: August 31, 2006 SUBJECT: EMERGENCY CARE OF WOUNDS (FIRST AID) 1. PURPOSE: Proper

More information

Diabetic Foot Infection. Dr David Orr Consultant Microbiologist Lancashire Teaching Hospitals

Diabetic Foot Infection. Dr David Orr Consultant Microbiologist Lancashire Teaching Hospitals Diabetic Foot Infection Dr David Orr Consultant Microbiologist Lancashire Teaching Hospitals History of previous amputation [odds ratio (OR)=19.9, P=.01], Peripheral vascular disease (OR=5.5, P=.007)

More information

Redefining Infection Management. Proven Clinical Outcomes

Redefining Infection Management. Proven Clinical Outcomes Proven Clinical Outcomes Proof of Bacteria-Binding1 In the first 30 seconds, 1 square centimeter of Cutimed Sorbact binds wound bacteria - after 2 hours, the amount of bacteria bound are more than would

More information

Treatment of septic peritonitis

Treatment of septic peritonitis Vet Times The website for the veterinary profession https://www.vettimes.co.uk Treatment of septic peritonitis Author : Andrew Linklater Categories : Companion animal, Vets Date : November 2, 2016 Septic

More information

Burn Infection & Laboratory Diagnosis

Burn Infection & Laboratory Diagnosis Burn Infection & Laboratory Diagnosis Introduction Burns are one the most common forms of trauma. 2 million fires each years 1.2 million people with burn injuries 100000 hospitalization 5000 patients die

More information

Treatment of Surgical Site Infection Meeting Quality Statement 6. Prof Peter Wilson University College London Hospitals

Treatment of Surgical Site Infection Meeting Quality Statement 6. Prof Peter Wilson University College London Hospitals Treatment of Surgical Site Infection Meeting Quality Statement 6 Prof Peter Wilson University College London Hospitals TEG Quality Standard 6 Treatment and effective antibiotic prescribing: People with

More information

Necrotizing Soft Tissue Infections: Emerging Bacterial Resistance

Necrotizing Soft Tissue Infections: Emerging Bacterial Resistance Necrotizing Soft Tissue Infections: Emerging Bacterial Resistance Eileen M. Bulger, MD Professor of Surgery Harborview Medical Center University of Washington Objectives Review definition & diagnostic

More information

CHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

CHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY CHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Antibiotics One of the most commonly used group of drugs In USA 23

More information

Infection/Wound & Dressings

Infection/Wound & Dressings Infection/Wound & Dressings Wendy McInnes ; Vascular Nurse Practitioner The Lyell McEwin Hospital, Adelaide, South Australia wendy.mcinnes@sa,gov.au 0447 051 036 WIFi Foot Infection Clinical Manifestation

More information

Biofilms no sign of infection but still not healing? <<Clinical Specialist>>

Biofilms no sign of infection but still not healing? <<Clinical Specialist>> Biofilms no sign of infection but still not healing? Chronic wounds Chronic wounds are increasing in prevalence as the population ages and the number of people living with multiple

More information

Antimicrobial Stewardship in the Hospital Setting

Antimicrobial Stewardship in the Hospital Setting GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 12 Antimicrobial Stewardship in the Hospital Setting Authors Dan Markley, DO, MPH, Amy L. Pakyz, PharmD, PhD, Michael Stevens, MD, MPH Chapter Editor

More information

No-leaching. No-resistance. No-toxicity. >99.999% Introducing BIOGUARD. Best-in-class dressings for your infection control program

No-leaching. No-resistance. No-toxicity. >99.999% Introducing BIOGUARD. Best-in-class dressings for your infection control program Introducing BIOGUARD No-leaching. >99.999% No-resistance. No-toxicity. Just cost-efficient, broad-spectrum, rapid effectiveness you can rely on. Best-in-class dressings for your infection control program

More information

Role of the nurse in diagnosing infection: The right sample, every time

Role of the nurse in diagnosing infection: The right sample, every time BROUGHT TO YOU BY Role of the nurse in diagnosing infection: The right sample, every time The module has been written by Shanika Anne-Marie Crusz and Amelia Joseph Authors affiliation: Department of Clinical

More information

CLPNA Pressure Ulcers ecourse: Module 5.6 Quiz II page 1

CLPNA Pressure Ulcers ecourse: Module 5.6 Quiz II page 1 CLPNA Pressure Ulcers ecourse: Module 5.6 Quiz II 1. What are the symptoms of an infected wound? a. Fever b. Edema c. Erythema d. Local pain and tenderness e. Induration of wound edge 2. A person with

More information

SUMMARY OF PRODUCT CHARACTERISTICS. Excipients: Contains 4% w/w cetyl alcohol and 7% w/w propylene glycol.

SUMMARY OF PRODUCT CHARACTERISTICS. Excipients: Contains 4% w/w cetyl alcohol and 7% w/w propylene glycol. SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT FLAMAZINE Cream 1 % w/w 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Contains Silver sulfadiazine 1 % w/w Excipients: Contains 4% w/w

More information

CWHHE OOHS Wound Care Management Formulary November 2016 v1.1

CWHHE OOHS Wound Care Management Formulary November 2016 v1.1 CWHHE OOHS Wound Care Management Formulary November 206 v. INTRODUCTION The CWHHE primary care wound care formulary has been developed by the CWHHE Out of Hospitals Services (OOHS) wound care reference

More information

Intra-Abdominal Infections. Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018

Intra-Abdominal Infections. Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018 Intra-Abdominal Infections Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018 Select guidelines Mazuski JE, et al. The Surgical Infection

More information

Scottish Medicines Consortium

Scottish Medicines Consortium Scottish Medicines Consortium daptomycin 350mg powder for concentrate for solution for infusion (Cubicin ) Chiron Corporation Limited No. (248/06) 10 March 2006 The Scottish Medicines Consortium (SMC)

More information

Healthcare-associated infections surveillance report

Healthcare-associated infections surveillance report Healthcare-associated infections surveillance report Methicillin-resistant Staphylococcus aureus (MRSA) Update, Q3 of 2017/18 Summary Table Q3 2017/18 Previous quarter (Q2 2017/18) Same quarter of previous

More information

Emergency Management of Life Threatening Problems

Emergency Management of Life Threatening Problems The management of wounds constitutes a significant topic of Emergency Medicine and I will briefly discuss with you first the emergency management of life threatening problems followed by wound assessment

More information

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018 Introduction to Chemotherapeutic Agents Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018 Antimicrobial Agents Substances that kill bacteria without harming the host.

More information

Wound Management. Elof Eriksson MD PhD Professor Emeritus, Harvard Medical School Chief Medical Officer, Applied Tissue Technologies LLC

Wound Management. Elof Eriksson MD PhD Professor Emeritus, Harvard Medical School Chief Medical Officer, Applied Tissue Technologies LLC Wound Management The use of a Platform Wound Device for Topical Treatment of Infections and for Delivery of Negative Pressure Elof Eriksson MD PhD Professor Emeritus, Harvard Medical School Chief Medical

More information

Antimicrobial Resistance & Wound Infections. Li Yang Hsu 8 th April 2015

Antimicrobial Resistance & Wound Infections. Li Yang Hsu 8 th April 2015 Antimicrobial Resistance & Wound Infections Li Yang Hsu 8 th April 2015 Potential Conflicts of Interest Research Funding: Pfizer Singapore AstraZeneca Janssen-Cilag Merck, Sharpe & Dohme Advisory Board:

More information

Submission for Reclassification

Submission for Reclassification Submission for Reclassification Fucithalmic (Fusidic Acid 1% Eye Drops) From Prescription Medicine to Restricted Medicine (Pharmacist Only Medicine) CSL Biotherapies (NZ) Limited 666 Great South Road Penrose

More information

Role of the general physician in the management of sepsis and antibiotic stewardship

Role of the general physician in the management of sepsis and antibiotic stewardship Role of the general physician in the management of sepsis and antibiotic stewardship Prof Martin Wiselka Dept of Infection and Tropical Medicine University Hospitals of Leicester Sepsis and antibiotic

More information

Standing Orders for the Treatment of Outpatient Peritonitis

Standing Orders for the Treatment of Outpatient Peritonitis Standing Orders for the Treatment of Outpatient Peritonitis 1. Definition of Peritonitis: a. Cloudy effluent. b. WBC > 100 cells/mm3 with >50% polymorphonuclear (PMN) cells with minimum 2 hour dwell. c.

More information

Antimicrobial Stewardship

Antimicrobial Stewardship Antimicrobial Stewardship Report: 11 th August 2016 Issue: As part of ensuring compliance with the National Safety and Quality Health Service Standards (NSQHS), Yea & District Memorial Hospital is required

More information

Prophylactic antibiotic timing and dosage. Dr. Sanjeev Singh AIMS, Kochi

Prophylactic antibiotic timing and dosage. Dr. Sanjeev Singh AIMS, Kochi Prophylactic antibiotic timing and dosage Dr. Sanjeev Singh AIMS, Kochi Meaning - Webster Medical Definition of prophylaxis plural pro phy lax es \-ˈlak-ˌsēz\play : measures designed to preserve health

More information

Define evidence based practices for selection and duration of antibiotics to treat suspected or confirmed neonatal sepsis

Define evidence based practices for selection and duration of antibiotics to treat suspected or confirmed neonatal sepsis GLOBAL AIM: Antibiotic Stewardship Perinatal Quality Improvement Teams (PQITs) will share strategies and lessons learned to develop potentially better practices and employ QI methodologies to establish

More information

Author - Dr. Josie Traub-Dargatz

Author - Dr. Josie Traub-Dargatz Author - Dr. Josie Traub-Dargatz Dr. Josie Traub-Dargatz is a professor of equine medicine at Colorado State University (CSU) College of Veterinary Medicine and Biomedical Sciences. She began her veterinary

More information

Invasive Group A Streptococcus (GAS)

Invasive Group A Streptococcus (GAS) Invasive Group A Streptococcus (GAS) Cause caused by a bacterium commonly found on the skin and in the throat transmitted by direct, indirect or droplet contact with secretions from the nose, and throat

More information

Give the Right Antibiotics in Trauma Mitchell J Daley, PharmD, BCPS

Give the Right Antibiotics in Trauma Mitchell J Daley, PharmD, BCPS Give the Right Antibiotics in Trauma Mitchell J Daley, PharmD, BCPS Clinical Pharmacy Specialist, Critical Care Dell Seton Medical Center at the University of Texas and Seton Healthcare Family Clinical

More information

Standing Orders for the Treatment of Outpatient Peritonitis

Standing Orders for the Treatment of Outpatient Peritonitis Standing Orders for the Treatment of Outpatient Peritonitis 1. Definition of Peritonitis: a. Cloudy effluent. b. WBC > 100 cells/mm3 with >50% polymorphonuclear (PMN) cells with minimum 2 hour dwell. c.

More information

Breastfeeding Challenges - Mastitis & Breast Abscess -

Breastfeeding Challenges - Mastitis & Breast Abscess - CLINICAL PRACTICE GUIDELINE Breastfeeding Challenges - Mastitis & Breast Abscess - SCOPE (Area): Maternity Unit, Emergency Department, Paediatrics SCOPE (Staff): Medical, Midwifery & Nursing DESIRED OUTCOME/OBJECTIVE

More information

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health

More information

Ear drops suspension. A smooth, uniform, white to off-white viscous suspension.

Ear drops suspension. A smooth, uniform, white to off-white viscous suspension. SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT OTOMAX EAR DROPS SUSPENSION 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of the veterinary medicinal product contains:

More information

The trinity of infection management: United Kingdom coalition statement

The trinity of infection management: United Kingdom coalition statement * The trinity of infection management: United Kingdom coalition statement This coalition statement, on behalf of our organizations (the UK Sepsis Trust, Royal College of Nursing, Infection Prevention Society,

More information

Who should read this document? 2. Key practice points 2. Background/ Scope/ Definitions 2. What is new in this version? 3

Who should read this document? 2. Key practice points 2. Background/ Scope/ Definitions 2. What is new in this version? 3 Neurosurgical infections (adult only) Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): as above Authors Division: DCSS & Tertiary

More information

SUMMARY OF PRODUCT CHARACTERISTICS. Cephacare flavour 50 mg tablets for cats and dogs. Excipients: For a full list of excipients, see section 6.1.

SUMMARY OF PRODUCT CHARACTERISTICS. Cephacare flavour 50 mg tablets for cats and dogs. Excipients: For a full list of excipients, see section 6.1. SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cephacare flavour 50 mg tablets for cats and dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: Active

More information

Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources

Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources Andrew Hunter, PharmD, BCPS Infectious Diseases Clinical Pharmacy Specialist Michael E. DeBakey VA Medical Center Andrew.hunter@va.gov

More information

Victorian Bushfires. February 7, 2009

Victorian Bushfires. February 7, 2009 Victorian Bushfires. February 7, 2009 Chris Heislers Veterinarian The Veterinary Surgery Yarrambat & North Warrandyte. Constraints to the animal welfare response. Council Media How do horses generally

More information

amoxycillin/clavulanate vs placebo in the prevention of infection after animal

amoxycillin/clavulanate vs placebo in the prevention of infection after animal Archives of Emergency Medicine, 1989, 6, 251-256 A comparative double blind study of amoxycillin/clavulanate vs placebo in the prevention of infection after animal bites P. H. BRAKENBURY & C. MUWANGA Accident

More information

The role of Infection Control Nurse in Prevention of Surgical Site Infection (SSI) April 2013

The role of Infection Control Nurse in Prevention of Surgical Site Infection (SSI) April 2013 The role of Infection Control Nurse in Prevention of Surgical Site Infection (SSI) April 2013 Impact of SSI 2 nd common health- care associated infection (HCAI) 14-16% of HCAI Post operation SSI prolong

More information

GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS

GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS Version 3.1 GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS Date ratified June 2008 Updated March 2009 Review date June 2010 Ratified by Authors Consultation Evidence base Changes

More information

Wound types and healing part three: classification of injuries

Wound types and healing part three: classification of injuries Vet Times The website for the veterinary profession https://www.vettimes.co.uk Wound types and healing part three: classification of injuries Author : Louise O Dwyer Categories : RVNs Date : July 1, 2010

More information

Antibiotic stewardship in long term care

Antibiotic stewardship in long term care Antibiotic stewardship in long term care Shira Doron, MD Associate Professor of Medicine Division of Geographic Medicine and Infectious Diseases Tufts Medical Center Boston, MA Consultant to Massachusetts

More information

Who should read this document 2. Key practice points 2. Background/ Scope/ Definitions 2. What is new in this version 3. Policy/Procedure/Guideline 3

Who should read this document 2. Key practice points 2. Background/ Scope/ Definitions 2. What is new in this version 3. Policy/Procedure/Guideline 3 Antibiotic Prophylaxis in Cranial Neurosurgery Antibiotic Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): as above Authors Division: DCSS & Tertiary

More information

Antibiotic Prophylaxis in Spinal Surgery Antibiotic Guidelines. Contents

Antibiotic Prophylaxis in Spinal Surgery Antibiotic Guidelines. Contents Antibiotic Prophylaxis in Spinal Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): Authors Division: DCSS & Tertiary Medicine Unique

More information

Silicone delivery liner assists easy release of 3M TM Ioban TM 2 Antimicrobial Incise Drape onto the skin.

Silicone delivery liner assists easy release of 3M TM Ioban TM 2 Antimicrobial Incise Drape onto the skin. 3M Health Care Incise Drapes A barrier to bacterial contamination Silicone delivery liner assists easy release of 3M TM Ioban TM 2 Antimicrobial Incise Drape onto the skin. 3M TM Ioban TM 2 Adhesive remains

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Zubrin 50 mg oral lyophilisates for dogs Zubrin 100 mg oral lyophilisates for dogs Zubrin 200 mg oral lyophilisates

More information

Surgical Site Infections (SSIs)

Surgical Site Infections (SSIs) Surgical Site Infections (SSIs) Postoperative infections presenting at any level Incisional superficial (skin, subcutaneous tissue) Incisional deep (fascial plane and muscles) Organ/space related (anatomic

More information

General Surgery Small Group Activity (Facilitator Notes) Curriculum for Antimicrobial Stewardship

General Surgery Small Group Activity (Facilitator Notes) Curriculum for Antimicrobial Stewardship General Surgery Small Group Activity (Facilitator Notes) Curriculum for Antimicrobial Stewardship Facilitator instructions: Read through the facilitator notes and make note of discussion points for each

More information

Unshakeable confidence

Unshakeable confidence NEW PRODUCT OF THE YEAR as voted by vets for the 2nd year running** Unshakeable confidence Osurnia is the only otitis externa* treatment that applies like a liquid and stays like a gel. Right where you

More information

ANIMAL CARE AND USE STANDARD

ANIMAL CARE AND USE STANDARD ANIMAL ETHICS ANIMAL CARE AND USE STANDARD The Animal Care & Use Standards are designed to provide guidance regarding good practice to institutional animal users and carers, as well as Animal Ethics Committees

More information

Overview of Infection Control and Prevention

Overview of Infection Control and Prevention Overview of Infection Control and Prevention Review of the Cesarean-section Antibiotic Prophylaxis Program in Jordan and Workshop on Rational Medicine Use and Infection Control Terry Green and Salah Gammouh

More information

Gastric Dilatation-Volvulus

Gastric Dilatation-Volvulus Gastric Dilatation-Volvulus The term "ACVS Diplomate" refers to a veterinarian who has been board certified in veterinary surgery. Only veterinarians who have successfully completed the certification requirements

More information

North West Neonatal Operational Delivery Network Working together to provide the highest standard of care for babies and families

North West Neonatal Operational Delivery Network Working together to provide the highest standard of care for babies and families Document Title and Reference : Guideline for the management of multi-drug resistant organisms (MDRO) Main Author (s) Simon Power Ratified by: GM NSG Date Ratified: February 2012 Review Date: March 2017

More information

The surgical site infection risk in developing countries. Yves BUISSON Société de Pathologie Exotique

The surgical site infection risk in developing countries. Yves BUISSON Société de Pathologie Exotique The surgical site infection risk in developing countries Yves BUISSON Société de Pathologie Exotique Surgical site infections Health-care-associated infections occurring within 30 days after surgery, or

More information

appropriate healthcare professionals employed at my pharmacy. I understand that I am

appropriate healthcare professionals employed at my pharmacy. I understand that I am Patient Group Direction: For the supply of Silver Sulfadiazine 1% Cream by Community Pharmacists in Somerset to patients for the topical treatment of minor localised impetigo under the Somerset Minor Ailments

More information

TREAT Steward. Antimicrobial Stewardship software with personalized decision support

TREAT Steward. Antimicrobial Stewardship software with personalized decision support TREAT Steward TM Antimicrobial Stewardship software with personalized decision support ANTIMICROBIAL STEWARDSHIP - Interdisciplinary actions to improve patient care Quality Assurance The aim of antimicrobial

More information

Dr Eleri Davies. Consultant Microbiologist and Infection Control Doctor, Public Health Wales NHS Trust

Dr Eleri Davies. Consultant Microbiologist and Infection Control Doctor, Public Health Wales NHS Trust Dr Eleri Davies Consultant Microbiologist and Infection Control Doctor, Public Health Wales NHS Trust Antimicrobial stewardship What is it? Why is it important? Treatment and management of catheter-associated

More information

Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE

Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE Crisis: Antibiotic Resistance Success Strategy WWW.optimistic-care.org

More information

Chapter 59 Wound Management Principles

Chapter 59 Wound Management Principles Chapter 59 Wound Management Principles Episode Overview: 1) List risk factors for wound infection 2) List the 5 stages of wound healing 3) List toxic doses of local anesthetics 4) List 3 types of wound

More information

Antimicrobial Stewardship in the Outpatient Setting. ELAINE LADD, PHARMD, ABAAHP, FAARFM OCTOBER 28th, 2016

Antimicrobial Stewardship in the Outpatient Setting. ELAINE LADD, PHARMD, ABAAHP, FAARFM OCTOBER 28th, 2016 Antimicrobial Stewardship in the Outpatient Setting ELAINE LADD, PHARMD, ABAAHP, FAARFM OCTOBER 28th, 2016 Abbreviations AMS - Antimicrobial Stewardship Program OP - Outpatient OPS - Outpatient Setting

More information

An Evidence Based Approach to Antibiotic Prophylaxis in Oral Surgery

An Evidence Based Approach to Antibiotic Prophylaxis in Oral Surgery An Evidence Based Approach to Antibiotic Prophylaxis in Oral Surgery Nicholas Makhoul DMD. MD. FRCD(C). Dip ABOMS. FACS. Director, Division of Oral and Maxillofacial Surgery Assistant Professor McGill

More information

Antimicrobial Selection and Therapy for Equine Musculoskeletal Trauma

Antimicrobial Selection and Therapy for Equine Musculoskeletal Trauma Antimicrobial Selection and Therapy for Equine Musculoskeletal Trauma Lucio Petrizzi DVM DECVS Università degli Studi di Teramo Surgical site infections (SSI) Microbial contamination unavoidable Infection

More information

Scottish Surveillance of Healthcare Infection Programme (SSHAIP) Health Protection Scotland SSI Surveillance Protocol 7th Edition 2017 Question &

Scottish Surveillance of Healthcare Infection Programme (SSHAIP) Health Protection Scotland SSI Surveillance Protocol 7th Edition 2017 Question & Contents General... 4 Pre-op... 4 Peri-op... 5 Post-op... 8 Caesarean Section... 12 Orthopaedics... 14 Large Bowel:... 15 Vascular... 17 General Pre-op Q: If a patient is an emergency admission is the

More information

Guidelines for the Medical management of Diabetic Foot Infection

Guidelines for the Medical management of Diabetic Foot Infection Guidelines for the Medical management of Diabetic Foot Infection Introduction and summary points - Foot infections in diabetic patients usually begin with skin ulceration - However, skin wounds with no

More information

Antibiotic Guideline: Empirical Treatment of Bone and Joint Infection in Adults

Antibiotic Guideline: Empirical Treatment of Bone and Joint Infection in Adults Antibiotic Guideline: Empirical Treatment of Bone and Joint Infection in Adults Document type: Prescribing guideline Version: 5.0 Author (name and designation) Samim Patel, Antimicrobial Lead Pharmacist

More information

HOSPITAL-ACQUIRED INFECTION/MRSA EYERUSALEM KIFLE AND GIFT IMUETINYAN OMOBOGBE PNURSS15

HOSPITAL-ACQUIRED INFECTION/MRSA EYERUSALEM KIFLE AND GIFT IMUETINYAN OMOBOGBE PNURSS15 HOSPITAL-ACQUIRED INFECTION/MRSA EYERUSALEM KIFLE AND GIFT IMUETINYAN OMOBOGBE PNURSS15 INTRODUCTION DEFINITIONS SIGNS AND SYMPTOMS RISK FACTORS DIAGNOSIS COMPLICATIONS PREVENTIONS TREATMENT PATIENT EDUCATION

More information

Source: Portland State University Population Research Center (

Source: Portland State University Population Research Center ( Methicillin Resistant Staphylococcus aureus (MRSA) Surveillance Report 2010 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Health Authority Updated:

More information

Antimicrobial stewardship

Antimicrobial stewardship Antimicrobial stewardship Magali Dodemont, Pharm. with the support of Wallonie-Bruxelles International WHY IMPLEMENT ANTIMICROBIAL STEWARDSHIP IN HOSPITALS? Optimization of antimicrobial use To limit the

More information

3.0 Treatment of Infection

3.0 Treatment of Infection 3.0 Treatment of Infection Antibiotics and Medicine National Curriculum Link Key Stage 3 Sc1:1a - 1c. 2a 2p Sc2: 2n Unit of Study Unit 8: Microbes and Disease Unit 9B: Fit and Healthy Unit 20: 20 th Century

More information

4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES

4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA BILLIE BARTEL, PHARMD, BCCCP APRIL 7 TH, 2017 DISCLOSURE I have had no financial relationship over the past 12 months with any commercial

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: Antibiotic treatment and monitoring for suspected or confirmed early-onset neonatal infection bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to

More information

Antimicrobial Stewardship Strategy:

Antimicrobial Stewardship Strategy: Antimicrobial Stewardship Strategy: Prospective audit with intervention and feedback Formal assessment of antimicrobial therapy by trained individuals, who make recommendations to the prescribing service

More information

Kristy Broaddus. Bite Wounds: Why are they so hard to manage? Bite Wounds 2/9/2016

Kristy Broaddus. Bite Wounds: Why are they so hard to manage? Bite Wounds 2/9/2016 Kristy Broaddus Bite Wounds: Why are they so hard to manage? Kristy Broaddus, DVM, MS, DACVS VESC Richmond VA Michigan State DVM Auburn University internship and surgery residency Oklahoma State University

More information

Bacterial infections in the urinary tract

Bacterial infections in the urinary tract Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2014 Bacterial infections in the urinary tract Gerber, B Posted at the Zurich

More information

[Version 8, 10/2012] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

[Version 8, 10/2012] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS [Version 8, 10/2012] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Mitex ear drops and cutaneous suspension for dogs and cats (AT, DE, EE, EL, ES, FR, HR, IT,

More information

General Approach to Infectious Diseases

General Approach to Infectious Diseases General Approach to Infectious Diseases 2 The pharmacotherapy of infectious diseases is unique. To treat most diseases with drugs, we give drugs that have some desired pharmacologic action at some receptor

More information

Inappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012

Inappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012 Inappropriate Use of Antibiotics and Clostridium difficile Infection Jocelyn Srigley, MD, FRCPC November 1, 2012 Financial Disclosures } No conflicts of interest } The study was supported by a Hamilton

More information

Antimicrobial Prophylaxis in Digestive Surgery

Antimicrobial Prophylaxis in Digestive Surgery Antimicrobial Prophylaxis in Digestive Surgery Toar JM. Lalisang, MD, PhD Digestive Surgery Division Cipto Mangunkusumo Hospital Medical Faculty Universitas Indonesia Antibiotic must be present before

More information

SURGICAL ANTIBIOTIC PROPHYLAXIS GUIDELINES WITHIN ORTHOPAEDIC SURGERY FOR ADULT PATIENTS

SURGICAL ANTIBIOTIC PROPHYLAXIS GUIDELINES WITHIN ORTHOPAEDIC SURGERY FOR ADULT PATIENTS SURGICAL ANTIBIOTIC PROPHYLAXIS GUIDELINES WITHIN ORTHOPAEDIC SURGERY FOR ADULT PATIENTS Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target audience, state if

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT RONAXAN 20mg Tablet 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: Active substance : Doxycycline (as doxycycline

More information

Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali. Lec 1

Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali. Lec 1 Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali Lec 1 28 Oct 2018 References Lippincott s IIIustrated Reviews / Pharmacology 6 th Edition Katzung and Trevor s Pharmacology / Examination

More information

Guidelines on prescribing antibiotics. For physicians and others in Denmark

Guidelines on prescribing antibiotics. For physicians and others in Denmark Guidelines on prescribing antibiotics 2013 For physicians and others in Denmark Guidelines on prescribing antibiotics For physicians and others in Denmark 2013 by the Danish Health and Medicines Authority.

More information

Veterinary. Advanced veterinary wound care

Veterinary. Advanced veterinary wound care Veterinary Advanced veterinary wound care An introduction to veterinary wound management Wounds are a common occurrence in veterinary practice and are most likely traumatic or resulting from surgical procedure.

More information

2/5/2016. Military Tourniquet PFN:SOMTRL0B. Terminal Learning Objective. Reason. Hours: 0.5

2/5/2016. Military Tourniquet PFN:SOMTRL0B. Terminal Learning Objective. Reason. Hours: 0.5 Military Tourniquet PFN:SOMTRL0B Hours: 0.5 Slide 1 Terminal Learning Objective Action: Communicate knowledge about the military tourniquet Condition: Given a lecture in a classroom environment Standard:

More information

TITLE: Antibacterial Sutures for Wound Closure after Surgery: A Review of the Clinical Effectiveness and Long-Term Adverse Effects

TITLE: Antibacterial Sutures for Wound Closure after Surgery: A Review of the Clinical Effectiveness and Long-Term Adverse Effects TITLE: Antibacterial Sutures for Wound Closure after Surgery: A Review of the Clinical Effectiveness and Long-Term Adverse Effects DATE: 17 September 2008 CONTEXT AND POLICY ISSUES: Surgical site infections

More information

CLINICAL PROTOCOL FOR COMMUNITY ACQUIRED PNEUMONIA. SCOPE: Western Australia. CORB score equal or above 1. All criteria must be met:

CLINICAL PROTOCOL FOR COMMUNITY ACQUIRED PNEUMONIA. SCOPE: Western Australia. CORB score equal or above 1. All criteria must be met: CLINICAL PROTOCOL F COMMUNITY ACQUIRED PNEUMONIA SCOPE: Western Australia All criteria must be met: Inclusion Criteria Exclusion Criteria CB score equal or above 1. Mild/moderate pneumonia confirmed by

More information

Principles of Animal Health

Principles of Animal Health Unit 15: Principles of Animal Health Unit code: F/503/1686 QCF level: 5 Credit value: 15 Aim This unit aims to develop learners understanding of animal health. Learners will have the opportunity to investigate

More information

ANTIMICROBIAL STEWARDSHIP START SMART THEN FOCUS Guidance for Antimicrobial Stewardship for SHSCT

ANTIMICROBIAL STEWARDSHIP START SMART THEN FOCUS Guidance for Antimicrobial Stewardship for SHSCT ANTIMICROBIAL STEWARDSHIP START SMART THEN FOCUS Guidance for Antimicrobial Stewardship for SHSCT CLINICAL GUIDELINES ID TAG Title: Prepared by Specialty / Division: Directorate: Antimicrobial Stewardship

More information

Antibiotic Resistance

Antibiotic Resistance Antibiotic Resistance ACVM information paper Background Within New Zealand and internationally, concerns have been raised about an association between antibiotics used routinely to protect the health of

More information

Wound Product Formulary

Wound Product Formulary Policy Number LCH-144 This document has been reviewed in line with the Policy Alignment Process for Liverpool Community Health NHS Trust Services. It is a valid Mersey Care document, however due to organisational

More information

Implementing Antibiotic Stewardship in Rural and Critical Access Hospitals

Implementing Antibiotic Stewardship in Rural and Critical Access Hospitals National Center for Emerging and Zoonotic Infectious Diseases Implementing Antibiotic Stewardship in Rural and Critical Access Hospitals Denise Cardo, MD Director, Division of Healthcare Quality Promotion,

More information

Methicillin-Resistant Staphylococcus aureus

Methicillin-Resistant Staphylococcus aureus Methicillin-Resistant Staphylococcus aureus By Karla Givens Means of Transmission and Usual Reservoirs Staphylococcus aureus is part of normal flora and can be found on the skin and in the noses of one

More information

Development and improvement of diagnostics to improve use of antibiotics and alternatives to antibiotics

Development and improvement of diagnostics to improve use of antibiotics and alternatives to antibiotics Priority Topic B Diagnostics Development and improvement of diagnostics to improve use of antibiotics and alternatives to antibiotics The overarching goal of this priority topic is to stimulate the design,

More information

Gynaecological Surgery in Adults Surgical Antibiotic Prophylaxis

Gynaecological Surgery in Adults Surgical Antibiotic Prophylaxis Gynaecological Surgery in Adults Surgical Antibiotic Prophylaxis Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target audience, state if Trust wide): Review date

More information

Review: topical mupirocin or fusidic acid may be more effective than oral antibiotics for limited non-bullous impetigo

Review: topical mupirocin or fusidic acid may be more effective than oral antibiotics for limited non-bullous impetigo Treatment Review: topical mupirocin or fusidic acid may be more effective than oral antibiotics for limited non-bullous impetigo James H Larcombe (Commentator) Dr S Koning, Department of General Practice,

More information

Surveillance of AMR in PHE: a multidisciplinary,

Surveillance of AMR in PHE: a multidisciplinary, Surveillance of AMR in PHE: a multidisciplinary, integrated approach Professor Neil Woodford Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit Crown copyright International

More information